ClinicalTrials.govpublic full text
Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
acute myeloid leukemia, high-risk and very high-risk myelodysplastic syndromes, mds, relapsed or refractory aml, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907384
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.